BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2809813
Number of visits today
176
Number of downloads
2061627
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Ye T, Zhang J, Wu D, Shi J, Kuang Z, Ma Y, Xu Q, Chen B, Kan C, Sun X, Han F. Empagliflozin Attenuates Obesity-Related Kidney Dysfunction and NLRP3 Inflammasome Activity Through the HO-1–Adiponectin Axis. Front Endocrinol 2022;13:907984. [DOI: 10.3389/fendo.2022.907984] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Shi J, Qiu H, Xu Q, Ma Y, Ye T, Kuang Z, Qu N, Kan C, Hou N, Han F, Sun X. Integrated multi-omics analyses reveal effects of empagliflozin on intestinal homeostasis in high-fat-diet mice. iScience 2023;26:105816. [PMID: 36636340 DOI: 10.1016/j.isci.2022.105816] [Reference Citation Analysis]
2 Chen X, Wang J, Lin Y, Liu Y, Zhou T. Signaling Pathways of Podocyte Injury in Diabetic Kidney Disease and the Effect of Sodium-Glucose Cotransporter 2 Inhibitors. Cells 2022;11. [PMID: 36497173 DOI: 10.3390/cells11233913] [Reference Citation Analysis]
3 Chen CL, Lin YC. Autophagy Dysregulation in Metabolic Associated Fatty Liver Disease: A New Therapeutic Target. Int J Mol Sci 2022;23:10055. [PMID: 36077452 DOI: 10.3390/ijms231710055] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345